T(2)-weighted microMRI and evoked potential of the visual system measurements during the development of

Melanie Martin1, Samuel D Reyes, Timothy D Hiltner

  • 1Department of Physics, University of Winnipeg, 515 Portage Avenue, Winnipeg, Manitoba, Canada, R3B 2E9. m.martin@uwinnipeg.ca

Neurochemical Research
|August 24, 2006
PubMed

Insights

This study used advanced magnetic resonance imaging and visual evoked potential techniques to track a dysmyelination and recovery process in JOE transgenic mice, revealing delayed central nervous system myelin development.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Biophysics

Background:

  • Oligodendrocytes are crucial for central nervous system (CNS) myelination.
  • Dysmyelinating diseases disrupt the formation and maintenance of myelin sheaths.
  • Genetic engineering allows for the creation of mouse models to study myelin disorders.

Purpose of the Study:

  • To longitudinally investigate a dysmyelinating disease with partial recovery in transgenic mice.
  • To assess the efficacy of non-invasive magnetic resonance imaging (microMRI) and visual evoked potential (VEP) techniques in tracking myelination dynamics.
  • To characterize the phenotype of JOE transgenic mice overexpressing golli J37 in oligodendrocytes.

Main Methods:

  • Utilized high-resolution 3D T2-weighted microMRI (11.7 T scanner) for in vivo imaging.
  • Employed non-invasive visual evoked potentials (VEPs) to assess visual system function.
  • Conducted a longitudinal study from 21 to 75 days of age in JOE transgenic mice and controls.

Main Results:

  • microMRI revealed global hypomyelination in JOE mice during peak myelination (21-42 days), with partial correction by >60 days.
  • VEPs indicated significant delays in CNS myelin development and persistent hypomyelination.
  • Observed a transient intention tremor in JOE mice, correlating with the myelination period.

Conclusions:

  • Non-invasive microMRI and VEPs are effective for spatially resolving myelination changes in developing mouse brains.
  • JOE transgenic mice exhibit a dysmyelinating phenotype with delayed myelination and partial recovery.
  • These findings highlight the utility of advanced imaging techniques for studying neurological development and disease.

Related Concept Videos